Percutaneous left atrial appendage closure in patients with gastrointestinal bleeding associated with oral anticoagulants Percutaneous left atrial appendage closure and gastrointestinal bleeding

被引:1
作者
Segura, Patricia Sanz [1 ,7 ]
Sanchez, Javier Jimeno [2 ]
Arbones-Mainar, Jose Miguel [3 ,4 ,5 ]
Lezcano, Juan Sanchez-Rubio [2 ]
Osuna, Gabriel Galache [2 ]
Monterde, Vanesa Bernal [4 ,6 ]
机构
[1] Royo Villanova Hosp, Gastroenterol Dept, Zaragoza, Spain
[2] Miguel Servet Univ Hosp, Intervent Cardiol Unit, Zaragoza, Spain
[3] Miguel Servet Univ Hosp, Translat Res Unit, Inst Aragones Ciencias Salud IACS, Zaragoza, Spain
[4] Inst Invest Sanitaria IIS Aragon, Zaragoza, Spain
[5] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr C, Madrid, Spain
[6] Miguel Servet Univ Hosp, Gastroenterol Dept, Zaragoza, Spain
[7] Royo Villanova Hosp, Gastroenterol Dept, Avda San Gregorio S-N, Zaragoza, Spain
关键词
Oral anticoagulation; gastrointestinal bleeding; interventional cardiology; atrial fibrillation; left atrial appendage occlusion; health resources; STROKE PROPHYLAXIS; WARFARIN THERAPY; FOLLOW-UP; FIBRILLATION; OCCLUSION; RISK; SAFETY; EFFICACY; WATCHMAN; METAANALYSIS;
D O I
10.1080/00365521.2023.2239973
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionPercutaneous left atrial appendage closure (LAAC) has shown non-inferiority compared to oral anticoagulation (OAC) in preventing atrial fibrillation (AF)-related stroke. The objective of this study was to assess whether LAAC reduces the incidence of gastrointestinal bleeding (GIB) and/or chronic anaemia associated with OAC, as well as the consumption of healthcare resources.Materials and MethodsProspective, single-center study from 2016 to 2022, LAAC was performed. Clinical, analytical and healthcare resource consumption data were collected (endoscopies, blood transfusions, hospital admissions) prior and 6 months after LAAC.Results43 patients were included, with an average age of 77.6 years. LAAC indication was upper, low and obscure GIB in 7 (16%), 8 (19%) and 28 patients (65%) respectively. GIB source was intestinal angiodysplasias in 27 patients (63%), occult origin in 12 (28%), and others (antral vascular ectasia, portal hypertension gastropathy, etc.) in 4 patients (9%). The mean number of packed red blood cells per patient before LAAC was (mean & PLUSMN; SD) 7.29 & PLUSMN; 5 vs 0.42 & PLUSMN; 1.3 (p < 0.001); endoscopic procedures were 4.34 & PLUSMN; 2.85 vs 0.27 & PLUSMN; 0.76 (p < 0.001); and hospitalizations 2.67 & PLUSMN; 2.14 vs 0.03 & PLUSMN; 0.17 (p < 0.001), with a hospital stay of 21.5 & PLUSMN; 17.3 vs 0.09 & PLUSMN; 0.5 days (p < 0.001) at 6 months post-intervention. Haemoglobin value increased from 8.1 & PLUSMN; 1.2g/dl to 12.4 & PLUSMN; 2.2g/dl (p < 0.001) at 6 months. No thromboembolic events were registered during a median follow-up of 16.6 months (range 6-65).ConclusionsLAAC could be a safe and effective alternative to OAC in patients with non-valvular AF presenting significant, recurrent or potentially unresolvable GIB. This intervention also leads to important savings in the consumption of healthcare resources.
引用
收藏
页码:1547 / 1554
页数:8
相关论文
共 46 条
[1]   Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study [J].
Abraham, Neena S. ;
Noseworthy, Peter A. ;
Yao, Xiaoxi ;
Sangaralingham, Lindsey R. ;
Shah, Nilay D. .
GASTROENTEROLOGY, 2017, 152 (05) :1014-+
[2]   Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study [J].
Aminian, Adel ;
De Backer, Ole ;
Nielsen-Kudsk, Jens Erik ;
Mazzone, Patrizio ;
Berti, Sergio ;
Fischer, Sven ;
Lund, Juha ;
Montorfano, Matteo ;
Lam, Simon Cheung Chi ;
Freixa, Xavier ;
Gage, Ryan ;
Diener, Hans-Christoph ;
Schmidt, Boris .
EUROINTERVENTION, 2021, 17 (09) :774-782
[3]   Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication [J].
Boersma, Lucas V. ;
Barr, Craig S. ;
Burke, Martin C. ;
Leon, Angel R. ;
Theuns, Dominic A. ;
Herre, John M. ;
Weiss, Raul ;
Kremers, Mark S. ;
Neuzil, Petr ;
Husby, Michael P. ;
Carter, Nathan ;
Stivland, Timothy M. ;
Gold, Michael R. .
HEART RHYTHM, 2017, 14 (03) :367-375
[4]   Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants [J].
Caldeira, D. ;
Barra, M. ;
Ferreira, A. ;
Rocha, A. ;
Augusto, A. ;
Pinto, F. J. ;
Costa, J. ;
Ferreira, J. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (11-12) :1239-1249
[5]   Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants [J].
Camm, Alan John ;
Cools, Frank ;
Virdone, Saverio ;
Bassand, Jean-Pierre ;
Fitzmaurice, David Andrew ;
Fox, Keith Alexander Arthur ;
Goldhaber, Samuel Zachary ;
Goto, Shinya ;
Haas, Sylvia ;
Mantovani, Lorenzo Giovanni ;
Kayani, Gloria ;
Turpie, Alexander Graham Grierson ;
Verheugt, Freek Willem Antoon ;
Kakkar, Ajay Kumar .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (12) :1425-1436
[6]   Treatment Discontinuations With New Oral Agents for Long-term Anticoagulation: Insights From a Meta-analysis of 18 Randomized Trials Including 101,801 Patients [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Giri, Jay S. ;
Ghosh, Joydeep ;
Mukherjee, Debabrata .
MAYO CLINIC PROCEEDINGS, 2014, 89 (07) :896-907
[7]  
Cruz-González I, 2020, REV ESP CARDIOL, V73, P28, DOI [10.1016/j.recesp.2019.02.018, 10.1016/j.rec.2019.02.013]
[8]  
Dar Tawseef, 2017, J Atr Fibrillation, V10, P1729, DOI 10.4022/jafib.1729
[9]   Interventional left atrial appendage closure in a patient with GAVE syndrome [J].
Fastner, Christian ;
Belle, Sebastian ;
Akin, Ibrahim .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (24) :1796-1799
[10]  
Fernández-Rodríguez Diego, 2014, Rev. esp. enferm. dig., V106, P350